Gamini Hethumuni
Endocrinology, Diabetes & Metabolism · San Gabriel, CANPI 1659459824
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.4%), speaking fees and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by AstraZeneca at 52.8% of the total. Reporting peaked in 2019 at $8,001 and has fallen 99.0% since, to $78 in 2023.
Across 347 payments — averaging $41.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$8K
- Novo Nordisk$2K
- Lilly USA, LLC$1K
- Mannkind Corporation$1K
- Amgen$599
- Boehringer Ingelheim$547
- plus $1K from 10 others
What the payments were for
- Speaking & faculty fees$6,50045%
- Travel & lodging$490%
- Food & beverage$7,52852%
- Education$2782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 45 | $7,579 |
| Novo Nordisk | 79 | $1,580 |
| Lilly USA, LLC | 55 | $1,394 |
| Mannkind Corporation | 67 | $1,196 |
| Amgen(2 entities) | 18 | $599 |
| Boehringer Ingelheim | 19 | $547 |
| Abbott | 15 | $472 |
| AbbVie | 11 | $255 |
| Sanofi-aventis U.S. LLC | 13 | $232 |
| Merck | 9 | $170 |
| Radius Health, Inc. | 4 | $97 |
| Dexcom, Inc. | 4 | $84 |
| Bayer | 3 | $58 |
| Endo Pharmaceuticals Inc. | 3 | $54 |
| Amarin Pharma, Inc. | 1 | $22 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,355 in reported general payments places this provider in the 85th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Other endocrinology, diabetes & metabolism in San Gabriel
- Juan FriasSan Diego$1.4M
- Joselito CabaccanSan Jose$1.4M
- Daniel NadeauNewport Beach$1.2M
- Yehuda HandelsmanTarzana$1M
- Helen BaronRancho Mirage$958K
- Ken FujiokaSan Diego$747K
- Minou TranPico Rivera$663K
- James ChuMonterey$639K
- Anthony HeaneyLos Angeles$588K
- Daniel Einhornla Jolla$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.